BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 8600166)

  • 21. Interleukin-3 (IL-3) receptors on rhesus monkey bone marrow cells: species specificity of human IL-3, binding characteristics, and lack of competition with GM-CSF.
    van Gils FC; Budel LM; Burger H; van Leen RW; Löwenberg B; Wagemaker G
    Exp Hematol; 1994 Mar; 22(3):248-55. PubMed ID: 7509288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of the common beta and specific alpha chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells.
    Colotta F; Bussolino F; Polentarutti N; Guglielmetti A; Sironi M; Bocchietto E; De Rossi M; Mantovani A
    Exp Cell Res; 1993 Jun; 206(2):311-7. PubMed ID: 7684696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-proliferative effect of IFN-gamma in immune regulation. II. IFN-gamma inhibits the proliferation of murine bone marrow cells stimulated with IL-3, IL-4, or granulocyte-macrophage colony-stimulating factor.
    Gajewski TF; Goldwasser E; Fitch FW
    J Immunol; 1988 Oct; 141(8):2635-42. PubMed ID: 2971726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells.
    Rogers SY; Bradbury D; Kozlowski R; Russell NH
    Exp Hematol; 1994 Jul; 22(7):593-8. PubMed ID: 7516889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Kupper T; Flood P; Coleman D; Horowitz M
    J Immunol; 1987 Jun; 138(12):4288-92. PubMed ID: 2953804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Granulocyte colony-stimulating factor receptors on human acute leukemia: biphenotypic leukemic cells possess granulocyte colony-stimulating factor receptors.
    Shimoda K; Okamura S; Harada N; Ikematsu W; Kondo S; Kawasaki C; Tanaka T; Etou T; Akashi K; Okamura T
    Cancer Res; 1992 Jun; 52(11):3052-5. PubMed ID: 1534271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
    Sallerfors B; Olofsson T; Lenhoff S
    Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human thymic epithelial cells produce granulocyte and macrophage colony-stimulating factors.
    Le PT; Kurtzberg J; Brandt SJ; Niedel JE; Haynes BF; Singer KH
    J Immunol; 1988 Aug; 141(4):1211-7. PubMed ID: 2456345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of evidence for abnormal autocrine or paracrine mechanisms underlying the uncontrolled proliferation of primitive chronic myeloid leukemia progenitor cells.
    Otsuka T; Eaves CJ; Humphries RK; Hogge DE; Eaves AC
    Leukemia; 1991 Oct; 5(10):861-8. PubMed ID: 1961020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel human myeloid leukemia cell line, NKM-1, coexpressing granulocyte colony-stimulating factor receptors and macrophage colony-stimulating factor receptors.
    Kataoka T; Morishita Y; Ogura M; Morishima Y; Towatari M; Kato Y; Inoue H; Saito H
    Cancer Res; 1990 Dec; 50(23):7703-9. PubMed ID: 1701353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-proliferative effect of IFN-gamma in immune regulation. IV. Murine CTL clones produce IL-3 and GM-CSF, the activity of which is masked by the inhibitory action of secreted IFN-gamma.
    Gajewski TF; Fitch FW
    J Immunol; 1990 Jan; 144(2):548-56. PubMed ID: 2104898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines.
    Shimizu N; Kita K; Masuya M; Nishii K; Matsuoka N; Morita N; Miwa H; Shirakawa S
    Exp Hematol; 1993 Jan; 21(1):119-25. PubMed ID: 7678084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paracrine and autocrine growth mechanisms of human stem cell factor (c-kit ligand) in myeloid leukemia.
    Pietsch T
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):285-6. PubMed ID: 7687773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human interleukin-3 inhibits the binding of granulocyte-macrophage colony-stimulating factor and interleukin-5 to basophils and strongly enhances their functional activity.
    Lopez AF; Eglinton JM; Lyons AB; Tapley PM; To LB; Park LS; Clark SC; Vadas MA
    J Cell Physiol; 1990 Oct; 145(1):69-77. PubMed ID: 1698795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interactions between colony-stimulating factors and the insulin family hormones for human myeloid leukemic cells.
    Oksenberg D; Dieckmann BS; Greenberg PL
    Cancer Res; 1990 Oct; 50(20):6471-7. PubMed ID: 1698537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
    Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
    Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effect of continuous versus cyclic maintenance chemotherapy on cytokine-induced myeloid colony growth.
    Ridgway D; Borzy MS
    Hematol Pathol; 1990; 4(2):87-92. PubMed ID: 2197267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of granulocyte-macrophage colony-stimulating factor but not IL-3 by normal and neoplastic human B lymphocytes.
    Zupo S; Perussia B; Baldi L; Corcione A; Dono M; Ferrarini M; Pistoia V
    J Immunol; 1992 Mar; 148(5):1423-30. PubMed ID: 1538127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE; Cooper S; Williams DE; Hangoc G; Gutterman JU; Vadhan-Raj S
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.
    Carlo-Stella C; Mangoni L; Piovani G; Almici C; Garau D; Caramatti C; Rizzoli V
    Bone Marrow Transplant; 1991 Oct; 8(4):265-73. PubMed ID: 1756324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.